Cormorant Global Healthcare Master Fund, Lp - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 192,823 shares made by Arthur A Levin , a net sale of 653,901 shares made by Sarah Boyce , and a net sale of 361,069 shares made by Michael F Maclean .

In summary, during the past 3 months, insiders sold 373,041 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 373,041 shares. During the past 18 months, 1,623,897 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,623,897 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 35,287 shares made by Karen Noblett , a net sale of 32,884 shares made by Ford Alfred J Jr , and a net sale of 6,450 shares made by Kari Leigh Keese .

In summary, during the past 3 months, insiders sold 2,961 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 2,961 shares. During the past 18 months, 133,356 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,356 shares.

Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 6,688 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 669 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 669 shares.

Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 92,017 shares made by Eben Tessari , and a net sale of 309,021 shares made by Sanj K Patel .

In summary, during the past 3 months, insiders sold 198,169 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 198,169 shares. During the past 18 months, 720,332 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 720,332 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 284,688 shares made by Pascal Deschatelets , a net sale of 433,087 shares made by Cedric Francois , and a net sale of 33,060 shares made by Timothy Eugene Sullivan .

In summary, during the past 3 months, insiders sold 5,063 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 5,063 shares. During the past 18 months, 1,149,235 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,149,235 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Clearside Biomedical Inc (CLSD). Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 90,000 shares made by , a net purchase of 580,222 shares made by Bradford T Whitmore , and a net purchase of 100,000 shares made by Anthony S Gibney .

In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 36,500 shares, with a net purchase of 36,500 shares. During the past 18 months, 30,900 shares of Clearside Biomedical Inc (CLSD) were sold and 798,035 shares were bought by its insiders, resulting in a net purchase of 767,135 shares.

Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc (CLRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc (CLRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cellectar Biosciences Inc (CLRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 115,885 shares made by Jean-pierre Sommadossi , a net sale of 359,606 shares made by Franklin M Berger , and a net sale of 17,544 shares made by Bruce Polsky .

In summary, during the past 3 months, insiders sold 359,606 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 359,606 shares. During the past 18 months, 563,073 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 563,073 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 110,172 shares made by Kevin C Tang ,

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 173,973 shares of Rain Oncology Inc (RAIN) were sold and 284,145 shares were bought by its insiders, resulting in a net purchase of 110,172 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 334,574 shares made by Cyrus Harmon , a net sale of 2,410,761 shares made by G. Walmsley Graham , and a net sale of 70,436 shares made by David C. Myles .

In summary, during the past 3 months, insiders sold 1,616,447 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 700,761 shares, with a net sale of 915,686 shares. During the past 18 months, 6,819,521 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,946,693 shares were bought by its insiders, resulting in a net sale of 3,872,828 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,000,000 shares made by Jonathan E Lim , a net purchase of 110,000 shares made by Alexander W. Casdin , and a net purchase of 10,000 shares made by Start Valerie Denise Harding .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 2,120,000 shares were bought by its insiders, resulting in a net purchase of 2,120,000 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Pyxis Oncology Inc (PYXS). Other recent insider transactions involving Pyxis Oncology Inc (PYXS) include a net purchase of 120,276 shares made by Pamela Ann Connealy , a net purchase of 10,000 shares made by Jitendra Wadhane , and a net sale of 36,558 shares made by Lara Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of Pyxis Oncology Inc (PYXS) in total and bought 88,850 shares, with a net purchase of 88,850 shares. During the past 18 months, 36,558 shares of Pyxis Oncology Inc (PYXS) were sold and 130,276 shares were bought by its insiders, resulting in a net purchase of 93,718 shares.

Pyxis Oncology Inc (PYXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 193,993 shares made by Adam K. Simpson , a net sale of 18,581 shares made by Cassia Cearley , and a net sale of 18,249 shares made by Thomas Joseph Russo .

In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 262,386 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 262,386 shares.

Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Immuneering Corp (IMRX). Other recent insider transactions involving Immuneering Corp (IMRX) include a net sale of 1,309,091 shares made by Cormorant Asset Management, Lp , a net purchase of 100,000 shares made by Peter Feinberg , and a net purchase of 57,965 shares made by Ann E Berman .

In summary, during the past 3 months, insiders sold 0 shares of Immuneering Corp (IMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,309,091 shares of Immuneering Corp (IMRX) were sold and 197,083 shares were bought by its insiders, resulting in a net sale of 1,112,008 shares.

Immuneering Corp (IMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 63,100 shares made by Hunter Gillies , a net sale of 121,434 shares made by Benjamin T Dake , and a net sale of 62,449 shares made by Timothy P Noyes .

In summary, during the past 3 months, insiders sold 0 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 377,861 shares of Aerovate Therapeutics Inc (AVTE) were sold and 928,110 shares were bought by its insiders, resulting in a net purchase of 550,249 shares.

Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 1,420,126 shares made by Arsani William , a net purchase of 8,194 shares made by Deepa Prasad , and a net purchase of 26,965 shares made by John P. Schmid .

In summary, during the past 3 months, insiders sold 3,806 shares of Design Therapeutics Inc (DSGN) in total and bought 0 shares, with a net sale of 3,806 shares. During the past 18 months, 818,680 shares of Design Therapeutics Inc (DSGN) were sold and 2,296,265 shares were bought by its insiders, resulting in a net purchase of 1,477,585 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , and a net sale of 2,817 shares made by Edmund Dunn .

In summary, during the past 3 months, insiders sold 157,895 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 157,895 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,860,491 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 6,000 shares made by Sylvia Mcbrinn , a net purchase of 50,000 shares made by Short Jay M Phd , and a net purchase of 20,000 shares made by Lawrence Steinman .

In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 83,495 shares were bought by its insiders, resulting in a net purchase of 83,495 shares.

BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Vigil Neuroscience Inc (VIGL). Other recent insider transactions involving Vigil Neuroscience Inc (VIGL) include a net purchase of 19,000 shares made by Ivana Magovcevic-liebisch , and a net purchase of 12,000 shares made by Budd Haeberlein Samantha L. .

In summary, during the past 3 months, insiders sold 0 shares of Vigil Neuroscience Inc (VIGL) in total and bought 27,000 shares, with a net purchase of 27,000 shares. During the past 18 months, 0 shares of Vigil Neuroscience Inc (VIGL) were sold and 31,000 shares were bought by its insiders, resulting in a net purchase of 31,000 shares.

Vigil Neuroscience Inc (VIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Biomea Fusion Inc (BMEA). Other recent insider transactions involving Biomea Fusion Inc (BMEA) include a net purchase of 12,509 shares made by Franco Valle , and a net purchase of 10,000 shares made by Hitchcock Michael J.m. .

In summary, during the past 3 months, insiders sold 0 shares of Biomea Fusion Inc (BMEA) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Biomea Fusion Inc (BMEA) were sold and 22,509 shares were bought by its insiders, resulting in a net purchase of 22,509 shares.

Biomea Fusion Inc (BMEA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,109 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net purchase of 76,000 shares made by Andrew D. Ashe .

In summary, during the past 3 months, insiders sold 555 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 555 shares. During the past 18 months, 2,623 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,377 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Ventyx Biosciences Inc (VTYX). Other recent insider transactions involving Ventyx Biosciences Inc (VTYX) include a net sale of 483,232 shares made by Nsv Partners Iii Lp , a net sale of 483,232 shares made by Somu Subramaniam , and a net purchase of 316,828 shares made by Raju Mohan .

In summary, during the past 3 months, insiders sold 13,161 shares of Ventyx Biosciences Inc (VTYX) in total and bought 630,000 shares, with a net purchase of 616,839 shares. During the past 18 months, 1,397,578 shares of Ventyx Biosciences Inc (VTYX) were sold and 630,000 shares were bought by its insiders, resulting in a net sale of 767,578 shares.

Ventyx Biosciences Inc (VTYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 174,168 shares made by Daniel Bensen , a net sale of 250,000 shares made by Todd Harris , and a net sale of 230,134 shares made by Nina S Kjellson .

In summary, during the past 3 months, insiders sold 352,080 shares of Tyra Biosciences Inc (TYRA) in total and bought 1,230,181 shares, with a net purchase of 878,101 shares. During the past 18 months, 654,302 shares of Tyra Biosciences Inc (TYRA) were sold and 1,230,181 shares were bought by its insiders, resulting in a net purchase of 575,879 shares.

Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Kineta Inc (KANT). Other recent insider transactions involving Kineta Inc (KANT) include a net purchase of 7,250 shares made by Raymond J. Bartoszek , a net purchase of 15,000 shares made by Shawn Iadonato , and a net purchase of 6,500 shares made by Craig W. Philips .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 45,250 shares were bought by its insiders, resulting in a net purchase of 45,250 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Ambrx Biopharma Inc (AMAM). Other recent insider transactions involving Ambrx Biopharma Inc (AMAM) include a net purchase of 2,152,738 shares made by Cormorant Asset Management, Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ambrx Biopharma Inc (AMAM) were sold and 2,152,738 shares were bought by its insiders, resulting in a net purchase of 2,152,738 shares.

Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made 1 insider transaction in GreenLight Biosciences Holdings PBC (GRNA) with a net sale of 9,188,659.

In summary, during the past 3 months, insiders sold 0 shares of GreenLight Biosciences Holdings PBC (GRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,188,659 shares of GreenLight Biosciences Holdings PBC (GRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,188,659 shares.

GreenLight Biosciences Holdings PBC (GRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Environmental Impact Acquisition Corp (ENVIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Environmental Impact Acquisition Corp (ENVIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Environmental Impact Acquisition Corp (ENVIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net sale of 200,000 shares made by Kristian Reich , a net sale of 184,740 shares made by Santos Da Silva Jorge , and a net purchase of 352,051 shares made by Bihua Chen .

In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 352,051 shares were bought by its insiders, resulting in a net sale of 2,303,689 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Global Healthcare Master Fund, Lp made no insider transaction in Ambrx Biopharma Inc (AMAM). Other recent insider transactions involving Ambrx Biopharma Inc (AMAM) include a net purchase of 1,307,311 shares made by Cormorant Asset Management, Lp , a net sale of 50,012 shares made by Daniel J. O'connor , and a net sale of 12,778 shares made by Sonja Nelson .

In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 62,790 shares of Ambrx Biopharma Inc (AMAM) were sold and 1,307,311 shares were bought by its insiders, resulting in a net purchase of 1,244,521 shares.

Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.